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reflow. However, in the clinical settings, interventional modalities prior to
reperfusion cannot be available. A putative mediator of PC, adenosine can
be obtained as a metabolite of ATP which is readily available for clinical use.
Thus we attempted to test whether the administration of ATP directly into
the reperfused area reduces the extent of no-reflow and infarct size. ATP
(4 mglkg/minl was administered for 10 min after reperfusion following 2hrs
occlusion of the left anterior descending artery (LAD) via the retrograde can-
nulation to the left main trunk through the segment distal to the first diago-
nal branch of LAD in the anesthetized open-chest dogs. Myocardial contrast
echocardiography (MCE) with Albunex at 2hrs of reperfusion revealed the
ratio of no-reflow area to risk area was smaller in ATP group than that in the
control group (0.14 ± 0.08 vs. 0.51 ± 0.12, mean ± SE, n = 5 each, p < 0.051.
nC-staining after 3hrs reperfusion revealed the reduction of IS normalized
by risk area in ATP group than that in the control group (13.9 ± 2.4% vs. 34.0
± 17.6%, P < 0.05). Furthermore, there was no advanced bradycardia during
the infusion of ATP. Thus we conclude that transient intracoronary infusion
of ATP into the reperfused area reduces the extent of no-reflow and IS. In-
tracoronary ATP administration can be a beneficial adjunctive therapy after
reperfusion in acute myocardial infarction.
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After Successful Direct Angloplasty Always Indicate
Poor Functional Recovery?
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Alsushi Tokuyama, Masahiko Harada, Toshiyuki Degawa, Shigeki Nishizawa,
So Yabuki, Tetsu Yamaguchi. Toho University Ohashi Hospital, Tokyo, Japan
Experimental studies have demonstrated that "no reflow" phenomenon af-
ter prolonged coronary occlusion indicates advanced myocardial necrosis.
In clinical settings, previous studies have suggested that presence of "no
reflow" phenomenon following thrombolysis is a useful predictor of poor
functional recovery. To test the hypothesis that "no reflow" phenomenon is
closely related to the recovery of regional wall motion in a reperfused AMI,
we studied 42 myocardial segments in 18 patients with AMI who achieved
successful direct angioplasty. MCE was performed immediately after direct
angioplasty and repeated 2 weeks later with intracoronary injection of soni-
cated albumin. Contrast effect in each segment was scored as 0-2 (0, 1 and
2 denoting no, partial and homogeneous contrast effect, respectively). 20-
Echo was performed at day-1 and repeated 1 month later. Wall motion (WMI
by 2D-Echo was scored as 0-3 (scores of 0 to 3 indicating dys/akinetic seg-
ments to normal. respectively). The relation between mean WM and MCE
score immediately after direct angioplasty was as follows:
MCE score day-l WM 1 MonlhWM Change
2 (n = 20) 1.1 ± 0.8** 1.7 ± 0.7*# 0.6 ± 09
1 (n = 7) 0.6 ± O.S* 1.4± 1.4# 0.9 ± 0.9
O(n = 15) 00 ± 0.0 O.S ± 1.0## O.S ± 1.0
*p < 0.01," p < 0.001 vs. MCE score = 0, #p < 0.05, ##p < 0.01 vs. day-l WM
Seven of 15 segments (47%) with MCE score = 0 immediately after di-
rect angioplasty showed functional recovery at 1 month later, and 6 of the 7
segments (86%) showed contrast enhancement at 2 weeks later restudy.
Conclusion: About one half of segments which showed no contrast en-
hancement immediately after direct angioplasty showed functional recovery
at 1 month later, and the majority of these segments showed contrast en-
hancement at 2 weeks later restudy. The "no reflow" phenomenon by MCE
immediately after successful direct angioplasty dose not always indicate
poor functional recovery.
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Chuwa Tei, James B. Seward. Mayo Clinic, Rochester MN
Imagent® US (AF0145, Alliance Pharmaceutical Corp.), a new hemodynam-
ically inert perfluorochemical echocardiographic contrast agent, produces
excellent left ventricular and blood pool contrast effect after intravenous ad-
ministration when imaged with conventional (2-D) ultrasound. We evaluated
the potential of Contrast Specific Imaging (Acuson) employing second har-
monic principles to further enhance the visualization of structures contain-
ing contrast agents. Transthoracic images were obtained during injections of
10-40 mg of the agent into the left femoral vein of seven closed chest dogs.
Coronary Dopplerflow was simultaneously measured using an intracoronary
Doppler wire. No alterations in flow velocities were observed with contrast
administration. There was heterogenous opacification of the myocardium
following contrast injection: a striking finding was of contrast-enhanced lin-
ear, branching structures in the myocardium consistent with coronary ves-
sels. Further exploration of the largest structures (2-3 mm diameter) in the
region of the basal ventricular septum was technically possible with pulsed
wave Doppler in two dogs. A characteristic coronary Doppler flow pattern
was observed (Fig 1a). Transthoracic Doppler flow velocities transiently in-
creased after intracoronary adenosine (Fig 1b). The calculated coronary flow
reserve ratio was similar to simultaneous intracoronary Doppler measure-
ments. Conclusions: Intramyocardial coronaryvasculature was observed and
coronary flow velocites were measured during transthoracic Contrast Spe-
cific Imaging with an intravenously administered contrast agent. These find-
ings suggest that noninvasive assessment of coronary blood flow is possible
with echocardiographic contrast enhancement.
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Transesophageal Echocardiography in the Evaluation
of the Thoracic Aorta - the Expanding View
Andrew J. Gresko, Alan Appelbe, Thomas Martin, Randolph P. Martin. Emory
University; Atlanta, Ga
The purpose of this study was to examine the accuracy, determine the spec-
trum of aortic disease and the effect that transesophageal echocardiography
has on the clinical management in a consecutive series of patients referred
for assessment of aortic disease.
A retrospective review of 75 patients undergoing TEE for aortic pathol-
ogy was performed. A wide spectrum of disease was encountered: atypical
aortic dissections (16). typical aortic dissections (22), aortic aneurysms (13).
atheromatous aortas (14), aortic transection (3). Takayasu's arteritis, aortic
contusion, coarctation and a penetrating ulcer. The sensitivity and specificity
was 96% and 98% respectively. In patients with aortic dissections, 42% of
aortic dissections were atypical due to: without an intimal falp (5). unusual 10-
calization (4). pre-existing surgery (3), unusual flap morphology (2), and aortic
complications (2). TEE altered the diagnosis made by computed tomography
in 26% and was the only test in 37%. Of these, 35% had immediate surgery
without further investigations. The TEE affected the management of 63% of
the patients with aortic dissections.
Conclusions: Transesophageal echocardiography is accurate across a
broad spectrum of aortic disease, not just aortic dissection. Atypical aortic
dissections are frequently encountered. Transesophageal echocardiography
altered or changed management in 63% of patients with aortic dissection.
